Medulloblastoma (MB) is a highly malignant pediatric cerebellar tumor comprising molecularly and clinically distinct subgroups. Group 3 and Group 4 MBs are believed to arise from overlapping progenitor populations within the developing rhombic lip (RL), when neuronal differentiation is stalled secondary to somatic dr...
Ran Tao, Rui-Jie Xu, Vincentius Martin et al.· Neuro-Oncology· 0 citations
Medulloblastoma is a biologically heterogeneous childhood cerebellar tumor harboring frequent chromatin-modifying gene alterations. How these alterations promote transcriptional programs governing malignancy remains poorly defined. To address this knowledge gap, we evaluated chromatin states across medulloblastoma subg...
Ran Tao, Serap Erkek-Ozhan, Bei-Si Xu et al.· Nature Genetics· 0 citations
Pineal region tumors are rare neoplasms that occur in all ages and account for less than 1% of all central nervous system (CNS) tumors in adults but are more frequent in children. Here, we describe a previously unrecognized tumor type of pineal origin characterized by a unique and consistent DNA methylation profile tha...
Helena Bode, A. Suwala, B. Gudenas et al.· Acta Neuropathologica· 0 citations
It is suggested that histone H3.3 K27M mutations drive diffuse midline glioma by ablating intrinsic regional differences in oligodendrocyte development, selectively expanding immature oligodendrocyte precursor cell populations in the brainstem while disrupting normal differentiation programs.
Jared M. Andrews, K. Budd, C. Kwon et al.· Nature Communications· 0 citations
By optimizing preanalytical and bioinformatic tools for pediatric settings, this study improved plasma-based cancer detection, molecular tumor characterization, and identification of targetable alterations, laying the groundwork for integration into personalized medicine programs and clinical trials.
K. Maass, P. Puranachot, S. Volz et al.· Genome Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.